PATENT CLAIM ANALYSIS

Application Number: 16140312
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "654000"]

Abstract:
Disclosed herein are methods of improving cognitive function in a patient as measured by, for example, improvement in score on a validated scale that measures cognitive function, such as the Behavior Rating Inventory of Executive Function (BRIEF), by administering the test to a patient and obtaining a pre-treatment test score, treating the patient with fenfluramine or its pharmaceutically acceptable salt, and after treatment, re-administering the test of cognitive function to the patient and obtaining a post-treatment score, to allow observation of an improvement in the test score. In some embodiments, the patient is also being treated for the symptoms of epilepsy.

Claim (Index 14):
A kit, comprising:\n a container comprising a plurality of doses of a formulation comprising a pharmaceutically acceptable carrier and an active ingredient comprising fenfluramine; and instructions for treating the patient with the formulation and assessing the patient's BRIEF score before and after treatment with the formulation.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.75385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15429646', '13887014', '14447253', '16140120', '15003161']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7907298664684875
- 35 USC 102 Novelty (BERT): 0.5259354701501564
- Combined Prediction Score: 0.7642504268366545
- Mean Citation Score: 318.878872
- Max Citation Score: 326.30322
- Similarity Product: 210.84517991822003

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test